Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Patent Expiration
Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil is Used for lowering high blood pressure. It was first introduced by Cosette Pharmaceuticals Inc
Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Patents
Given below is the list of patents protecting Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tribenzor | US5616599 | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
Apr 25, 2016
(Expired) | Cosette |
| Tribenzor |
US5616599 (Pediatric) | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
Oct 25, 2016
(Expired) | Cosette |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil Generics
Several generic applications have been filed for Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil. The first generic version for Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil was by Endo Operations Ltd and was approved on Oct 26, 2016. And the latest generic version is by Teva Pharmaceuticals Usa and was approved on Nov 3, 2016.
Given below is the list of companies who have filed for Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil generic.
1. TORRENT
Torrent Pharmaceuticals Ltd has filed for 5 different strengths of generic version for Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE; 25MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 5MG BASE; 12.5MG; 20MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 5MG BASE; 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 5MG BASE; 25MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 10MG BASE; 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
2. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 5 different strengths of generic version for Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE; 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Nov 3, 2016 |
| EQ 5MG BASE; 25MG; 40MG | tablet | Prescription | ORAL | AB | Nov 3, 2016 |
| EQ 10MG BASE; 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Nov 3, 2016 |
| EQ 10MG BASE; 25MG; 40MG | tablet | Prescription | ORAL | AB | Nov 3, 2016 |
| EQ 5MG BASE; 12.5MG; 20MG | tablet | Prescription | ORAL | AB | Nov 3, 2016 |
3. ENDO OPERATIONS
Endo Operations Ltd has filed for 5 different strengths of generic version for Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil. All of these versions come by the name OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE; 25MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 5MG BASE; 12.5MG; 20MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 5MG BASE; 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 5MG BASE; 25MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |
| EQ 10MG BASE; 12.5MG; 40MG | tablet | Prescription | ORAL | AB | Oct 26, 2016 |